Clinical trial
Physical ACtivity in patiEnts With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice (PACE)
NCT01756235 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Physical ACtivity in patiEnts With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice (PACE)
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- October 31, 2015
- Enrollment
- 462 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis